6:15 PM
 | 
Dec 18, 2012
 |  BC Extra  |  Politics & Policy

IMI expanding ND4BB

Europe's Innovative Medicines Initiative is expanding its NewDrugs4BadBugs (ND4BB) initiative, which was launched in May to support the development of new antibiotics. The details came in IMI's eighth call for proposals to fund public-private partnerships addressing three topics, including antimicrobial resistance. IMI is now seeking to fund projects focused on innovative trial design and...

Read the full 251 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >